These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 11602574

  • 21. New insights into redox response modulation in Fanconi's anemia cells by hydrogen peroxide and glutathione depletors.
    Cuccarolo P, Viaggi S, Degan P.
    FEBS J; 2012 Jul; 279(14):2479-94. PubMed ID: 22578062
    [Abstract] [Full Text] [Related]

  • 22. Effects of buthionine sulfoximine treatment on cellular glutathione levels and cytotoxicities of cisplatin, carboplatin and radiation in human stomach and ovarian cancer cell lines.
    Lee KS, Kim HK, Moon HS, Hong YS, Kang JH, Kim DJ, Park JG.
    Korean J Intern Med; 1992 Jul; 7(2):111-7. PubMed ID: 1306072
    [Abstract] [Full Text] [Related]

  • 23. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells.
    Chen G, Waxman DJ.
    Biochem Pharmacol; 1994 Mar 15; 47(6):1079-87. PubMed ID: 8147907
    [Abstract] [Full Text] [Related]

  • 24. Ceramide-mediated apoptosis in lung epithelial cells is regulated by glutathione.
    Lavrentiadou SN, Chan C, Kawcak T, Ravid T, Tsaba A, van der Vliet A, Rasooly R, Goldkorn T.
    Am J Respir Cell Mol Biol; 2001 Dec 15; 25(6):676-84. PubMed ID: 11726392
    [Abstract] [Full Text] [Related]

  • 25. Removal of glutathione produces apoptosis and necrosis in HepG2 cells overexpressing CYP2E1.
    Wu D, Cederbaum AI.
    Alcohol Clin Exp Res; 2001 Apr 15; 25(4):619-28. PubMed ID: 11329505
    [Abstract] [Full Text] [Related]

  • 26. Auranofin induces apoptosis and necrosis in HeLa cells via oxidative stress and glutathione depletion.
    You BR, Shin HR, Han BR, Kim SH, Park WH.
    Mol Med Rep; 2015 Feb 15; 11(2):1428-34. PubMed ID: 25370167
    [Abstract] [Full Text] [Related]

  • 27. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
    Mistry P, Loh SY, Kelland LR, Harrap KR.
    Int J Cancer; 1993 Nov 11; 55(5):848-56. PubMed ID: 8244583
    [Abstract] [Full Text] [Related]

  • 28. GSH depletion, protein S-glutathionylation and mitochondrial transmembrane potential hyperpolarization are early events in initiation of cell death induced by a mixture of isothiazolinones in HL60 cells.
    Di Stefano A, Frosali S, Leonini A, Ettorre A, Priora R, Di Simplicio FC, Di Simplicio P.
    Biochim Biophys Acta; 2006 Feb 11; 1763(2):214-25. PubMed ID: 16458373
    [Abstract] [Full Text] [Related]

  • 29. Synergistic cytotoxicity of topoisomerase I inhibitors with alkylating agents and etoposide in human brain tumor cell lines.
    Janss AJ, Cnaan A, Zhao H, Shpilsky A, Levow C, Sutton L, Phillips PC.
    Anticancer Drugs; 1998 Aug 11; 9(7):641-52. PubMed ID: 9773809
    [Abstract] [Full Text] [Related]

  • 30. Simultaneous treatment with 1-beta-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cells.
    Takemura H, Urasaki Y, Yoshida A, Fukushima T, Ueda T.
    Cancer Res; 2001 Jan 01; 61(1):172-7. PubMed ID: 11196156
    [Abstract] [Full Text] [Related]

  • 31. Arachidonic acid converts the glutathione depletion-induced apoptosis to necrosis by promoting lipid peroxidation and reducing caspase-3 activity in rat glioma cells.
    Higuchi Y, Yoshimoto T.
    Arch Biochem Biophys; 2002 Apr 01; 400(1):133-40. PubMed ID: 11913980
    [Abstract] [Full Text] [Related]

  • 32. Adenovirus-mediated overexpression of catalase in the cytosolic or mitochondrial compartment protects against toxicity caused by glutathione depletion in HepG2 cells expressing CYP2E1.
    Marí M, Bai J, Cederbaum AI.
    J Pharmacol Exp Ther; 2002 Apr 01; 301(1):111-8. PubMed ID: 11907164
    [Abstract] [Full Text] [Related]

  • 33. Enhancement of melphalan activity by buthionine sulfoximine and electroporation in melanoma cells.
    Ongaro A, Pellati A, De Mattei M, De Terlizzi F, Rossi CR, Campana LG.
    Anticancer Drugs; 2015 Mar 01; 26(3):284-92. PubMed ID: 25514113
    [Abstract] [Full Text] [Related]

  • 34. Modulation of cisplatin toxicity in blood platelets by glutathione depletion.
    Olas B, Wachowicz B.
    Anticancer Drugs; 1998 Jun 01; 9(5):473-8. PubMed ID: 9660546
    [Abstract] [Full Text] [Related]

  • 35. Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases.
    Sánchez Y, Calle C, de Blas E, Aller P.
    Chem Biol Interact; 2009 Nov 10; 182(1):37-44. PubMed ID: 19720055
    [Abstract] [Full Text] [Related]

  • 36. Curcumin sensitizes lung adenocarcinoma cells to apoptosis via intracellular redox status mediated pathway.
    Kaushik G, Kaushik T, Yadav SK, Sharma SK, Ranawat P, Khanduja KL, Pathak CM.
    Indian J Exp Biol; 2012 Dec 10; 50(12):853-61. PubMed ID: 23986968
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of glutathione synthesis overcomes Bcl-2-mediated topoisomerase inhibitor resistance and induces nonapoptotic cell death via mitochondrial-independent pathway.
    Yoshida A, Takemura H, Inoue H, Miyashita T, Ueda T.
    Cancer Res; 2006 Jun 01; 66(11):5772-80. PubMed ID: 16740716
    [Abstract] [Full Text] [Related]

  • 38. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.
    Ozols RF, Louie KG, Plowman J, Behrens BC, Fine RL, Dykes D, Hamilton TC.
    Biochem Pharmacol; 1987 Jan 01; 36(1):147-53. PubMed ID: 3801051
    [Abstract] [Full Text] [Related]

  • 39. The interaction of buthionine sulphoximide (BSO) and the topoisomerase I inhibitor CPT-11.
    Sawyer TE, Bonner JA.
    Br J Cancer Suppl; 1996 Jul 01; 27():S109-13. PubMed ID: 8763860
    [Abstract] [Full Text] [Related]

  • 40. Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma.
    Colla R, Izzotti A, De Ciucis C, Fenoglio D, Ravera S, Speciale A, Ricciarelli R, Furfaro AL, Pulliero A, Passalacqua M, Traverso N, Pronzato MA, Domenicotti C, Marengo B.
    Oncotarget; 2016 Oct 25; 7(43):70715-70737. PubMed ID: 27683112
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.